Global Factor VIII Deficiency Treatment Market Insights and Forecast to 2031

Report ID: 1380077 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Hemophilia A Drugs
        1.2.3 Hemophilia A Inhibitors Treatment
        1.2.4 Von Willebrand Disease Treatment
    1.3 Market by Application
        1.3.1 Global Factor VIII Deficiency Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Factor VIII Deficiency Treatment Market Perspective (2017-2028)
    2.2 Factor VIII Deficiency Treatment Growth Trends by Region
        2.2.1 Factor VIII Deficiency Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Factor VIII Deficiency Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Factor VIII Deficiency Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Factor VIII Deficiency Treatment Market Dynamics
        2.3.1 Factor VIII Deficiency Treatment Industry Trends
        2.3.2 Factor VIII Deficiency Treatment Market Drivers
        2.3.3 Factor VIII Deficiency Treatment Market Challenges
        2.3.4 Factor VIII Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Factor VIII Deficiency Treatment Players by Revenue
        3.1.1 Global Top Factor VIII Deficiency Treatment Players by Revenue (2017-2022)
        3.1.2 Global Factor VIII Deficiency Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Factor VIII Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Factor VIII Deficiency Treatment Revenue
    3.4 Global Factor VIII Deficiency Treatment Market Concentration Ratio
        3.4.1 Global Factor VIII Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Factor VIII Deficiency Treatment Revenue in 2021
    3.5 Factor VIII Deficiency Treatment Key Players Head office and Area Served
    3.6 Key Players Factor VIII Deficiency Treatment Product Solution and Service
    3.7 Date of Enter into Factor VIII Deficiency Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Factor VIII Deficiency Treatment Breakdown Data by Type
    4.1 Global Factor VIII Deficiency Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2023-2028)
5 Factor VIII Deficiency Treatment Breakdown Data by Application
    5.1 Global Factor VIII Deficiency Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Factor VIII Deficiency Treatment Market Size (2017-2028)
    6.2 North America Factor VIII Deficiency Treatment Market Size by Type
        6.2.1 North America Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
        6.2.2 North America Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
        6.2.3 North America Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
    6.3 North America Factor VIII Deficiency Treatment Market Size by Application
        6.3.1 North America Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
        6.3.2 North America Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
        6.3.3 North America Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
    6.4 North America Factor VIII Deficiency Treatment Market Size by Country
        6.4.1 North America Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
        6.4.2 North America Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Factor VIII Deficiency Treatment Market Size (2017-2028)
    7.2 Europe Factor VIII Deficiency Treatment Market Size by Type
        7.2.1 Europe Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
    7.3 Europe Factor VIII Deficiency Treatment Market Size by Application
        7.3.1 Europe Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
    7.4 Europe Factor VIII Deficiency Treatment Market Size by Country
        7.4.1 Europe Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type
        8.2.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application
        8.3.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region
        8.4.1 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Factor VIII Deficiency Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Factor VIII Deficiency Treatment Market Size (2017-2028)
    9.2 Latin America Factor VIII Deficiency Treatment Market Size by Type
        9.2.1 Latin America Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
    9.3 Latin America Factor VIII Deficiency Treatment Market Size by Application
        9.3.1 Latin America Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
    9.4 Latin America Factor VIII Deficiency Treatment Market Size by Country
        9.4.1 Latin America Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type
        10.2.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Factor VIII Deficiency Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application
        10.3.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Factor VIII Deficiency Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country
        10.4.1 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Factor VIII Deficiency Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Factor VIII Deficiency Treatment Introduction
        11.1.4 Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Takeda
        11.2.1 Takeda Company Details
        11.2.2 Takeda Business Overview
        11.2.3 Takeda Factor VIII Deficiency Treatment Introduction
        11.2.4 Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.2.5 Takeda Recent Developments
    11.3 Bayer HealthCare
        11.3.1 Bayer HealthCare Company Details
        11.3.2 Bayer HealthCare Business Overview
        11.3.3 Bayer HealthCare Factor VIII Deficiency Treatment Introduction
        11.3.4 Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.3.5 Bayer HealthCare Recent Developments
    11.4 CSL
        11.4.1 CSL Company Details
        11.4.2 CSL Business Overview
        11.4.3 CSL Factor VIII Deficiency Treatment Introduction
        11.4.4 CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.4.5 CSL Recent Developments
    11.5 Grifols
        11.5.1 Grifols Company Details
        11.5.2 Grifols Business Overview
        11.5.3 Grifols Factor VIII Deficiency Treatment Introduction
        11.5.4 Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.5.5 Grifols Recent Developments
    11.6 Novo Nordisk
        11.6.1 Novo Nordisk Company Details
        11.6.2 Novo Nordisk Business Overview
        11.6.3 Novo Nordisk Factor VIII Deficiency Treatment Introduction
        11.6.4 Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.6.5 Novo Nordisk Recent Developments
    11.7 F. Hoffmann-La Roche
        11.7.1 F. Hoffmann-La Roche Company Details
        11.7.2 F. Hoffmann-La Roche Business Overview
        11.7.3 F. Hoffmann-La Roche Factor VIII Deficiency Treatment Introduction
        11.7.4 F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.7.5 F. Hoffmann-La Roche Recent Developments
    11.8 Kedrion
        11.8.1 Kedrion Company Details
        11.8.2 Kedrion Business Overview
        11.8.3 Kedrion Factor VIII Deficiency Treatment Introduction
        11.8.4 Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.8.5 Kedrion Recent Developments
    11.9 Octapharma
        11.9.1 Octapharma Company Details
        11.9.2 Octapharma Business Overview
        11.9.3 Octapharma Factor VIII Deficiency Treatment Introduction
        11.9.4 Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.9.5 Octapharma Recent Developments
    11.10 Biogen Idec
        11.10.1 Biogen Idec Company Details
        11.10.2 Biogen Idec Business Overview
        11.10.3 Biogen Idec Factor VIII Deficiency Treatment Introduction
        11.10.4 Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.10.5 Biogen Idec Recent Developments
    11.11 BioMarin Pharmaceutical
        11.11.1 BioMarin Pharmaceutical Company Details
        11.11.2 BioMarin Pharmaceutical Business Overview
        11.11.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Introduction
        11.11.4 BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.11.5 BioMarin Pharmaceutical Recent Developments
    11.12 Sangamo Therapeutics
        11.12.1 Sangamo Therapeutics Company Details
        11.12.2 Sangamo Therapeutics Business Overview
        11.12.3 Sangamo Therapeutics Factor VIII Deficiency Treatment Introduction
        11.12.4 Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.12.5 Sangamo Therapeutics Recent Developments
    11.13 Spark Therapeutics
        11.13.1 Spark Therapeutics Company Details
        11.13.2 Spark Therapeutics Business Overview
        11.13.3 Spark Therapeutics Factor VIII Deficiency Treatment Introduction
        11.13.4 Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.13.5 Spark Therapeutics Recent Developments
    11.14 Swedish Orphan Biovitrum
        11.14.1 Swedish Orphan Biovitrum Company Details
        11.14.2 Swedish Orphan Biovitrum Business Overview
        11.14.3 Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Introduction
        11.14.4 Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.14.5 Swedish Orphan Biovitrum Recent Developments
    11.15 Uniqure NV
        11.15.1 Uniqure NV Company Details
        11.15.2 Uniqure NV Business Overview
        11.15.3 Uniqure NV Factor VIII Deficiency Treatment Introduction
        11.15.4 Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.15.5 Uniqure NV Recent Developments
    11.16 Amarna Therapeutics
        11.16.1 Amarna Therapeutics Company Details
        11.16.2 Amarna Therapeutics Business Overview
        11.16.3 Amarna Therapeutics Factor VIII Deficiency Treatment Introduction
        11.16.4 Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.16.5 Amarna Therapeutics Recent Developments
    11.17 Dimension Therapeutics
        11.17.1 Dimension Therapeutics Company Details
        11.17.2 Dimension Therapeutics Business Overview
        11.17.3 Dimension Therapeutics Factor VIII Deficiency Treatment Introduction
        11.17.4 Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022)
        11.17.5 Dimension Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Hemophilia A Drugs
    Table 3. Key Players of Hemophilia A Inhibitors Treatment
    Table 4. Key Players of Von Willebrand Disease Treatment
    Table 5. Global Factor VIII Deficiency Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Factor VIII Deficiency Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Factor VIII Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Factor VIII Deficiency Treatment Market Share by Region (2017-2022)
    Table 9. Global Factor VIII Deficiency Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Factor VIII Deficiency Treatment Market Share by Region (2023-2028)
    Table 11. Factor VIII Deficiency Treatment Market Trends
    Table 12. Factor VIII Deficiency Treatment Market Drivers
    Table 13. Factor VIII Deficiency Treatment Market Challenges
    Table 14. Factor VIII Deficiency Treatment Market Restraints
    Table 15. Global Factor VIII Deficiency Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Factor VIII Deficiency Treatment Revenue Share by Players (2017-2022)
    Table 17. Global Top Factor VIII Deficiency Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2021)
    Table 18. Ranking of Global Top Factor VIII Deficiency Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Factor VIII Deficiency Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Factor VIII Deficiency Treatment Product Solution and Service
    Table 22. Date of Enter into Factor VIII Deficiency Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Factor VIII Deficiency Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Factor VIII Deficiency Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Factor VIII Deficiency Treatment Revenue Share by Application (2017-2022)
    Table 30. Global Factor VIII Deficiency Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Factor VIII Deficiency Treatment Revenue Share by Application (2023-2028)
    Table 32. North America Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Factor VIII Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Factor VIII Deficiency Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Factor VIII Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Pfizer Company Details
    Table 63. Pfizer Business Overview
    Table 64. Pfizer Factor VIII Deficiency Treatment Product
    Table 65. Pfizer Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 66. Pfizer Recent Developments
    Table 67. Takeda Company Details
    Table 68. Takeda Business Overview
    Table 69. Takeda Factor VIII Deficiency Treatment Product
    Table 70. Takeda Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 71. Takeda Recent Developments
    Table 72. Bayer HealthCare Company Details
    Table 73. Bayer HealthCare Business Overview
    Table 74. Bayer HealthCare Factor VIII Deficiency Treatment Product
    Table 75. Bayer HealthCare Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 76. Bayer HealthCare Recent Developments
    Table 77. CSL Company Details
    Table 78. CSL Business Overview
    Table 79. CSL Factor VIII Deficiency Treatment Product
    Table 80. CSL Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 81. CSL Recent Developments
    Table 82. Grifols Company Details
    Table 83. Grifols Business Overview
    Table 84. Grifols Factor VIII Deficiency Treatment Product
    Table 85. Grifols Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 86. Grifols Recent Developments
    Table 87. Novo Nordisk Company Details
    Table 88. Novo Nordisk Business Overview
    Table 89. Novo Nordisk Factor VIII Deficiency Treatment Product
    Table 90. Novo Nordisk Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 91. Novo Nordisk Recent Developments
    Table 92. F. Hoffmann-La Roche Company Details
    Table 93. F. Hoffmann-La Roche Business Overview
    Table 94. F. Hoffmann-La Roche Factor VIII Deficiency Treatment Product
    Table 95. F. Hoffmann-La Roche Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 96. F. Hoffmann-La Roche Recent Developments
    Table 97. Kedrion Company Details
    Table 98. Kedrion Business Overview
    Table 99. Kedrion Factor VIII Deficiency Treatment Product
    Table 100. Kedrion Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 101. Kedrion Recent Developments
    Table 102. Octapharma Company Details
    Table 103. Octapharma Business Overview
    Table 104. Octapharma Factor VIII Deficiency Treatment Product
    Table 105. Octapharma Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 106. Octapharma Recent Developments
    Table 107. Biogen Idec Company Details
    Table 108. Biogen Idec Business Overview
    Table 109. Biogen Idec Factor VIII Deficiency Treatment Product
    Table 110. Biogen Idec Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 111. Biogen Idec Recent Developments
    Table 112. BioMarin Pharmaceutical Company Details
    Table 113. BioMarin Pharmaceutical Business Overview
    Table 114. BioMarin Pharmaceutical Factor VIII Deficiency Treatment Product
    Table 115. BioMarin Pharmaceutical Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 116. BioMarin Pharmaceutical Recent Developments
    Table 117. Sangamo Therapeutics Company Details
    Table 118. Sangamo Therapeutics Business Overview
    Table 119. Sangamo Therapeutics Factor VIII Deficiency Treatment Product
    Table 120. Sangamo Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 121. Sangamo Therapeutics Recent Developments
    Table 122. Spark Therapeutics Company Details
    Table 123. Spark Therapeutics Business Overview
    Table 124. Spark Therapeutics Factor VIII Deficiency Treatment Product
    Table 125. Spark Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 126. Spark Therapeutics Recent Developments
    Table 127. Swedish Orphan Biovitrum Company Details
    Table 128. Swedish Orphan Biovitrum Business Overview
    Table 129. Swedish Orphan Biovitrum Factor VIII Deficiency Treatment Product
    Table 130. Swedish Orphan Biovitrum Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 131. Swedish Orphan Biovitrum Recent Developments
    Table 132. Uniqure NV Company Details
    Table 133. Uniqure NV Business Overview
    Table 134. Uniqure NV Factor VIII Deficiency Treatment Product
    Table 135. Uniqure NV Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 136. Uniqure NV Recent Developments
    Table 137. Amarna Therapeutics Company Details
    Table 138. Amarna Therapeutics Business Overview
    Table 139. Amarna Therapeutics Factor VIII Deficiency Treatment Product
    Table 140. Amarna Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 141. Amarna Therapeutics Recent Developments
    Table 142. Dimension Therapeutics Company Details
    Table 143. Dimension Therapeutics Business Overview
    Table 144. Dimension Therapeutics Factor VIII Deficiency Treatment Product
    Table 145. Dimension Therapeutics Revenue in Factor VIII Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 146. Dimension Therapeutics Recent Developments
    Table 147. Research Programs/Design for This Report
    Table 148. Key Data Information from Secondary Sources
    Table 149. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Factor VIII Deficiency Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Hemophilia A Drugs Features
    Figure 3. Hemophilia A Inhibitors Treatment Features
    Figure 4. Von Willebrand Disease Treatment Features
    Figure 5. Global Factor VIII Deficiency Treatment Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Other Case Studies
    Figure 9. Factor VIII Deficiency Treatment Report Years Considered
    Figure 10. Global Factor VIII Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Factor VIII Deficiency Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Factor VIII Deficiency Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Factor VIII Deficiency Treatment Market Share by Players in 2021
    Figure 14. Global Top Factor VIII Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor VIII Deficiency Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Factor VIII Deficiency Treatment Revenue in 2021
    Figure 16. North America Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
    Figure 18. North America Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
    Figure 19. North America Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
    Figure 20. United States Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
    Figure 26. Germany Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Factor VIII Deficiency Treatment Market Size Share by Region (2017-2028)
    Figure 36. China Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
    Figure 46. Mexico Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Factor VIII Deficiency Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Factor VIII Deficiency Treatment Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Factor VIII Deficiency Treatment Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Factor VIII Deficiency Treatment Market Size Share by Country (2017-2028)
    Figure 52. Turkey Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Factor VIII Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Pfizer Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 56. Takeda Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 57. Bayer HealthCare Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 58. CSL Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 59. Grifols Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 60. Novo Nordisk Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 62. Kedrion Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 63. Octapharma Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 64. Biogen Idec Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 65. BioMarin Pharmaceutical Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 66. Sangamo Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 67. Spark Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 68. Swedish Orphan Biovitrum Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 69. Uniqure NV Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 70. Amarna Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 71. Dimension Therapeutics Revenue Growth Rate in Factor VIII Deficiency Treatment Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Takeda
Bayer HealthCare
CSL
Grifols
Novo Nordisk
F. Hoffmann-La Roche
Kedrion
Octapharma
Biogen Idec
BioMarin Pharmaceutical
Sangamo Therapeutics
Spark Therapeutics
Swedish Orphan Biovitrum
Uniqure NV
Amarna Therapeutics
Dimension Therapeutics
Frequently Asked Questions
Factor VIII Deficiency Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Factor VIII Deficiency Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Factor VIII Deficiency Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Fanless PC

Fanless PC market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More

Farm Mechanization

Farm Mechanization market is segmented by players, region (country), by Type and by Application.  ... Read More

Fast Attack Craft

Fast Attack Craft market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More